English

MiddleBrook Pharmaceuticals, Inc.

EDGAR

Quarterly report (10-Q) · filed 2010-05-07

28 filing records in this dataset, filed from 2003-11-25 to 2010-05-07. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.44 million USD

2006-12-31 · USD

Exact inputs and evidence

Revenue: 4810410 USD Source
Revenue: 2369975 USD Source

Operating margin

-561.34%

2006-12-31 · %

Exact inputs and evidence

Operating Income: -43352003 USD Source
Operating Income: -29652777 USD Source
Revenue: 4810410 USD Source
Revenue: 2369975 USD Source

Operating cash flow

-13.1 million USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -36331302 USD Source
Operating Cash Flow: -23219613 USD Source

Free cash flow

-13.6 million USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -36331302 USD Source
Operating Cash Flow: -23219613 USD Source
Capital Expenditure: 550929 USD Source
Capital Expenditure: 50653 USD Source

Cash and cash equivalents: 10.9 million USD 2010-03-31 Source
Exact value

10938000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

7.2 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Revenue: 860231 USD · 2006-01-01 – 2006-03-31 Source
Revenue: 336357 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 3566563 USD · 2006-07-01 – 2006-09-30 Source
Revenue: 4810410 USD · 2006-01-01 – 2006-12-31 Source
Revenue: 2369975 USD · 2006-01-01 – 2006-09-30 Source

Net income

-67.4 million USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Net income: -19585000 USD · 2009-04-01 – 2009-06-30 Source
Net income: -16964000 USD · 2009-07-01 – 2009-09-30 Source
Net income: -62326000 USD · 2009-01-01 – 2009-12-31 Source
Net income: -46555000 USD · 2009-01-01 – 2009-09-30 Source
Net income: -15126000 USD · 2010-01-01 – 2010-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-05-07.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2009-12-31
Operating income: 9 of 11 periods available· newest 2009-12-31
Net income: 9 of 11 periods available· newest 2009-12-31
Operating cash flow: 9 of 11 periods available· newest 2009-12-31
Capital expenditure: 9 of 11 periods available· newest 2009-12-31
Total assets: 8 of 11 periods available· newest 2009-12-31
Total liabilities: 8 of 11 periods available· newest 2009-12-31
Current assets: 8 of 11 periods available· newest 2009-12-31
Current liabilities: 8 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+67.7%

Prior period

USD 8.85 million

2008-01-01 – 2008-12-31
Current period

USD 14.84 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

14844000 − 8849000 = 5995000 USD

8849000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
14844000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Year-over-year change in Revenue: 5995000 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 14844000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#12603 Input fundies:Revenue: 8849000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#12603
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 20.75 million

Prior period

−USD 41.58 million

2008-01-01 – 2008-12-31
Current period

−USD 62.33 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-62326000 − -41580000 = -20746000 USD

-41580000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-62326000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Year-over-year change in Net income: -20746000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -62326000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#12915 Input fundies:NetIncome: -41580000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#12915
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 34.16 million

Prior period

−USD 24 million

2008-01-01 – 2008-12-31
Current period

−USD 58.16 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-58158000 − -23996000 = -34162000 USD

-23996000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-58158000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Year-over-year change in Operating cash flow: -34162000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -58158000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599 Input fundies:OperatingCashFlow: -23996000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-87.9%

Prior period

USD 812,000

2008-01-01 – 2008-12-31
Current period

USD 98,000

2009-01-01 – 2009-12-31

Exact inputs and evidence

98000 − 812000 = -714000 USD

812000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
98000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Year-over-year change in Capital expenditure: -714000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 98000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686 Input fundies:CapitalExpenditure: 812000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 14.84 million 100% of revenue
Cost of revenue USD 2.25 million 15% of revenue
Operating expenses USD 75.14 million 506% of revenue
Operating income −USD 62.55 million −421% of revenue
Tax, interest and other Derived −USD 227,000 −1.5% of revenue
Net income −USD 62.33 million −420% of revenue

Cash

Operating cash flow −USD 58.16 million −392% of revenue
Capital expenditure USD 98,000 0.7% of revenue
Free cash flow Derived −USD 58.26 million −392% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Not shown: operating income or net income is not reported.
2003 Operating loss: operating costs were 635% of revenue.
2004 Operating loss: operating costs were 405% of revenue.
2005 Operating loss: operating costs were 302% of revenue.
2006 Operating loss: operating costs were 1,001% of revenue.
2007 Operating loss: operating costs were 484% of revenue.
2008 Operating loss: operating costs were 510% of revenue.
2009 Operating loss: operating costs were 521% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	0	14179009 Derived	-14179009	-55014 Derived	-14123995	-14235654 Derived	Source 2002-01-01 – 2002-12-31: 0 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -14179009 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -14123995 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -12795977 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1439677 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	3625000	23022082 Derived	-19397082	1578102 Derived	-20975184	-20047351 Derived	Source 2003-01-01 – 2003-12-31: 3625000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -19397082 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -20975184 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -11084240 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 8963111 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	11358032	46032193 Derived	-34674161	-669448 Derived	-34004713	-21687342 Derived	Source 2004-01-01 – 2004-12-31: 11358032 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -34674161 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -34004713 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -15486665 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 6200677 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	16847690	50806752 Derived	-33959062	-970485 Derived	-32988577	-26812686 Derived	Source 2005-01-01 – 2005-12-31: 16847690 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -33959062 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -32988577 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -24889805 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 1922881 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	4810410	48162413 Derived	-43352003	-1361849 Derived	-41990154	-36882231 Derived	Source 2006-01-01 – 2006-12-31: 4810410 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -43352003 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -41990154 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -36331302 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 550929 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	10457000	50578000 Derived	-40121000	2128000 Derived	-42249000	-36658000 Derived	Source 2007-01-01 – 2007-12-31: 10457000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -40121000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -42249000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -35261000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 1397000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	8849000	45098000 Derived	-36249000	5331000 Derived	-41580000	-24808000 Derived	Source 2008-01-01 – 2008-12-31: 8849000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -36249000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -41580000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -23996000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 812000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	14844000	77397000 Derived	-62553000	-227000 Derived	-62326000	-58256000 Derived	Source 2009-01-01 – 2009-12-31: 14844000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -62553000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -62326000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -58158000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 98000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 14.8M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	0	Revenue: 0 Open source
20032003-12-31	Revenue	3625000	Revenue: 3625000 Open source
20042004-12-31	Revenue	11358032	Revenue: 11358032 Open source
20052005-12-31	Revenue	16847690	Revenue: 16847690 Open source
20062006-12-31	Revenue	4810410	Revenue: 4810410 Open source
20072007-12-31	Revenue	10457000	Revenue: 10457000 Open source
20082008-12-31	Revenue	8849000	Revenue: 8849000 Open source
20092009-12-31	Revenue	14844000	Revenue: 14844000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

67.7% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 3625000 Open source Revenue: 0 Open source
20042004-12-31	Year over year	213.3%	Revenue: 11358032 Open source Revenue: 3625000 Open source
20052005-12-31	Year over year	48.3%	Revenue: 16847690 Open source Revenue: 11358032 Open source
20062006-12-31	Year over year	-71.4%	Revenue: 4810410 Open source Revenue: 16847690 Open source
20072007-12-31	Year over year	117.4%	Revenue: 10457000 Open source Revenue: 4810410 Open source
20082008-12-31	Year over year	-15.4%	Revenue: 8849000 Open source Revenue: 10457000 Open source
20092009-12-31	Year over year	67.7%	Revenue: 14844000 Open source Revenue: 8849000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -421.4% 2009

Net margin -419.9% 2009

Free cash flow margin -392.5% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	Not reported	Operating Income: -14179009 Open source Revenue: 0 Open source
20032003-12-31	Operating margin	-535.1%	Operating Income: -19397082 Open source Revenue: 3625000 Open source
20042004-12-31	Operating margin	-305.3%	Operating Income: -34674161 Open source Revenue: 11358032 Open source
20052005-12-31	Operating margin	-201.6%	Operating Income: -33959062 Open source Revenue: 16847690 Open source
20062006-12-31	Operating margin	-901.2%	Operating Income: -43352003 Open source Revenue: 4810410 Open source
20072007-12-31	Operating margin	-383.7%	Operating Income: -40121000 Open source Revenue: 10457000 Open source
20082008-12-31	Operating margin	-409.6%	Operating Income: -36249000 Open source Revenue: 8849000 Open source
20092009-12-31	Operating margin	-421.4%	Operating Income: -62553000 Open source Revenue: 14844000 Open source
20022002-12-31	Net margin	Not reported	Net Income: -14123995 Open source Revenue: 0 Open source
20032003-12-31	Net margin	-578.6%	Net Income: -20975184 Open source Revenue: 3625000 Open source
20042004-12-31	Net margin	-299.4%	Net Income: -34004713 Open source Revenue: 11358032 Open source
20052005-12-31	Net margin	-195.8%	Net Income: -32988577 Open source Revenue: 16847690 Open source
20062006-12-31	Net margin	-872.9%	Net Income: -41990154 Open source Revenue: 4810410 Open source
20072007-12-31	Net margin	-404%	Net Income: -42249000 Open source Revenue: 10457000 Open source
20082008-12-31	Net margin	-469.9%	Net Income: -41580000 Open source Revenue: 8849000 Open source
20092009-12-31	Net margin	-419.9%	Net Income: -62326000 Open source Revenue: 14844000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -12795977 Open source Capital Expenditure: 1439677 Open source
20032003-12-31	Free cash flow margin	-553%	Revenue: 3625000 Open source Operating Cash Flow: -11084240 Open source Capital Expenditure: 8963111 Open source
20042004-12-31	Free cash flow margin	-190.9%	Revenue: 11358032 Open source Operating Cash Flow: -15486665 Open source Capital Expenditure: 6200677 Open source
20052005-12-31	Free cash flow margin	-159.1%	Revenue: 16847690 Open source Operating Cash Flow: -24889805 Open source Capital Expenditure: 1922881 Open source
20062006-12-31	Free cash flow margin	-766.7%	Revenue: 4810410 Open source Operating Cash Flow: -36331302 Open source Capital Expenditure: 550929 Open source
20072007-12-31	Free cash flow margin	-350.6%	Revenue: 10457000 Open source Operating Cash Flow: -35261000 Open source Capital Expenditure: 1397000 Open source
20082008-12-31	Free cash flow margin	-280.3%	Revenue: 8849000 Open source Operating Cash Flow: -23996000 Open source Capital Expenditure: 812000 Open source
20092009-12-31	Free cash flow margin	-392.5%	Revenue: 14844000 Open source Operating Cash Flow: -58158000 Open source Capital Expenditure: 98000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -58.2M 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-12795977	Operating Cash Flow: -12795977 Open source
20032003-12-31	Operating cash flow	-11084240	Operating Cash Flow: -11084240 Open source
20042004-12-31	Operating cash flow	-15486665	Operating Cash Flow: -15486665 Open source
20052005-12-31	Operating cash flow	-24889805	Operating Cash Flow: -24889805 Open source
20062006-12-31	Operating cash flow	-36331302	Operating Cash Flow: -36331302 Open source
20072007-12-31	Operating cash flow	-35261000	Operating Cash Flow: -35261000 Open source
20082008-12-31	Operating cash flow	-23996000	Operating Cash Flow: -23996000 Open source
20092009-12-31	Operating cash flow	-58158000	Operating Cash Flow: -58158000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -58.3M 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	-14235654	Operating Cash Flow: -12795977 Open source Capital Expenditure: 1439677 Open source
20032003-12-31	Free cash flow	-20047351	Operating Cash Flow: -11084240 Open source Capital Expenditure: 8963111 Open source
20042004-12-31	Free cash flow	-21687342	Operating Cash Flow: -15486665 Open source Capital Expenditure: 6200677 Open source
20052005-12-31	Free cash flow	-26812686	Operating Cash Flow: -24889805 Open source Capital Expenditure: 1922881 Open source
20062006-12-31	Free cash flow	-36882231	Operating Cash Flow: -36331302 Open source Capital Expenditure: 550929 Open source
20072007-12-31	Free cash flow	-36658000	Operating Cash Flow: -35261000 Open source Capital Expenditure: 1397000 Open source
20082008-12-31	Free cash flow	-24808000	Operating Cash Flow: -23996000 Open source Capital Expenditure: 812000 Open source
20092009-12-31	Free cash flow	-58256000	Operating Cash Flow: -58158000 Open source Capital Expenditure: 98000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

69.1% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Liabilities / assets	36.7%	Total Liabilities: 3320687 Open source Total Assets: 9058523 Open source
20032003-12-31	Liabilities / assets	16.7%	Total Liabilities: 14024923 Open source Total Assets: 84174843 Open source
20042004-12-31	Liabilities / assets	35%	Total Liabilities: 21403761 Open source Total Assets: 61142140 Open source
20052005-12-31	Liabilities / assets	42.3%	Total Liabilities: 24454881 Open source Total Assets: 57796892 Open source
20062006-12-31	Liabilities / assets	71.7%	Total Liabilities: 30133749 Open source Total Assets: 42005769 Open source
20072007-12-31	Liabilities / assets	93.7%	Total Liabilities: 22176136 Open source Total Assets: 23665795 Open source
20082008-12-31	Liabilities / assets	24.4%	Total Liabilities: 23262000 Open source Total Assets: 95193000 Open source
20092009-12-31	Liabilities / assets	69.1%	Total Liabilities: 29122000 Open source Total Assets: 42175000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.74× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Current assets / current liabilities	1.94×	Current Assets: 4232423 Open source Current Liabilities: 2185457 Open source
20032003-12-31	Current assets / current liabilities	8.01×	Current Assets: 69214586 Open source Current Liabilities: 8645560 Open source
20042004-12-31	Current assets / current liabilities	2.69×	Current Assets: 31626180 Open source Current Liabilities: 11754010 Open source
20052005-12-31	Current assets / current liabilities	3.29×	Current Assets: 31744270 Open source Current Liabilities: 9653422 Open source
20062006-12-31	Current assets / current liabilities	1.13×	Current Assets: 19443050 Open source Current Liabilities: 17255849 Open source
20072007-12-31	Current assets / current liabilities	0.61×	Current Assets: 4470340 Open source Current Liabilities: 7273296 Open source
20082008-12-31	Current assets / current liabilities	8.56×	Current Assets: 78161000 Open source Current Liabilities: 9134000 Open source
20092009-12-31	Current assets / current liabilities	1.74×	Current Assets: 26058000 Open source Current Liabilities: 14980000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 7.18 million Exact value Exact value: -7184576 USD 2001-01-01 – 2001-12-31: -7184576 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2001-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -7184576 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7184576 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-04-000759.txt#15109 The citation records this snapshot. The page link may show a newer release later.	−USD 6.4 million Exact value Exact value: -6404469 USD 2001-01-01 – 2001-12-31: -6404469 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2001-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -6404469 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6404469 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-04-000759.txt#15464 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1479401 USD 2001-01-01 – 2001-12-31: 1479401 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2001-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 1479401 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1479401 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-04-000759.txt#15567 The citation records this snapshot. The page link may show a newer release later.	−USD 7.88 million Calculation and evidence -6404469 − 1479401 USD Exact free cash flow: -7883870 USD 2001-01-01 – 2001-12-31: -6404469 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 1479401 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2001-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -7883870 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6404469 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-04-000759.txt#15464 Input fundies:CapitalExpenditure: 1479401 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-04-000759.txt#15567 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 14.12 million Exact value Exact value: -14123995 USD 2002-01-01 – 2002-12-31: -14123995 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2002-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -14123995 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14123995 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-05-000961.txt#16561 The citation records this snapshot. The page link may show a newer release later.	−USD 12.8 million Exact value Exact value: -12795977 USD 2002-01-01 – 2002-12-31: -12795977 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2002-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -12795977 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12795977 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-05-000961.txt#16910 The citation records this snapshot. The page link may show a newer release later.	USD 1.44 million Exact value Exact value: 1439677 USD 2002-01-01 – 2002-12-31: 1439677 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2002-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 1439677 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1439677 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-05-000961.txt#17025 The citation records this snapshot. The page link may show a newer release later.	−USD 14.24 million Calculation and evidence -12795977 − 1439677 USD Exact free cash flow: -14235654 USD 2002-01-01 – 2002-12-31: -12795977 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1439677 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2002-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -14235654 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12795977 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-05-000961.txt#16910 Input fundies:CapitalExpenditure: 1439677 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-05-000961.txt#17025 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 20.98 million Exact value Exact value: -20975184 USD 2003-01-01 – 2003-12-31: -20975184 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2003-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -20975184 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20975184 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-06-001508.txt#30323 The citation records this snapshot. The page link may show a newer release later.	−USD 11.08 million Exact value Exact value: -11084240 USD 2003-01-01 – 2003-12-31: -11084240 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2003-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -11084240 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11084240 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-06-001508.txt#31120 The citation records this snapshot. The page link may show a newer release later.	USD 8.96 million Exact value Exact value: 8963111 USD 2003-01-01 – 2003-12-31: 8963111 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2003-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 8963111 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8963111 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-06-001508.txt#31429 The citation records this snapshot. The page link may show a newer release later.	−USD 20.05 million Calculation and evidence -11084240 − 8963111 USD Exact free cash flow: -20047351 USD 2003-01-01 – 2003-12-31: -11084240 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 8963111 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2003-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -20047351 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11084240 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-06-001508.txt#31120 Input fundies:CapitalExpenditure: 8963111 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-06-001508.txt#31429 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 34 million Exact value Exact value: -34004713 USD 2004-01-01 – 2004-12-31: -34004713 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2004-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -34004713 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34004713 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-07-001287.txt#32635 The citation records this snapshot. The page link may show a newer release later.	−USD 15.49 million Exact value Exact value: -15486665 USD 2004-01-01 – 2004-12-31: -15486665 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2004-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -15486665 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15486665 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-07-001287.txt#33388 The citation records this snapshot. The page link may show a newer release later.	USD 6.2 million Exact value Exact value: 6200677 USD 2004-01-01 – 2004-12-31: 6200677 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2004-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 6200677 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6200677 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-07-001287.txt#33697 The citation records this snapshot. The page link may show a newer release later.	−USD 21.69 million Calculation and evidence -15486665 − 6200677 USD Exact free cash flow: -21687342 USD 2004-01-01 – 2004-12-31: -15486665 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 6200677 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2004-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -21687342 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15486665 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-07-001287.txt#33388 Input fundies:CapitalExpenditure: 6200677 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-07-001287.txt#33697 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 32.99 million Exact value Exact value: -32988577 USD 2005-01-01 – 2005-12-31: -32988577 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2005-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -32988577 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32988577 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-07-001287.txt#32635 The citation records this snapshot. The page link may show a newer release later.	−USD 24.89 million Exact value Exact value: -24889805 USD 2005-01-01 – 2005-12-31: -24889805 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2005-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -24889805 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24889805 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-08-001205.txt#31883 The citation records this snapshot. The page link may show a newer release later.	USD 1.92 million Exact value Exact value: 1922881 USD 2005-01-01 – 2005-12-31: 1922881 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2005-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 1922881 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1922881 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-08-001205.txt#32139 The citation records this snapshot. The page link may show a newer release later.	−USD 26.81 million Calculation and evidence -24889805 − 1922881 USD Exact free cash flow: -26812686 USD 2005-01-01 – 2005-12-31: -24889805 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 1922881 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2005-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -26812686 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24889805 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-08-001205.txt#31883 Input fundies:CapitalExpenditure: 1922881 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-08-001205.txt#32139 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 41.99 million Exact value Exact value: -41990154 USD 2006-01-01 – 2006-12-31: -41990154 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2006-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -41990154 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -41990154 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-07-001287.txt#32635 The citation records this snapshot. The page link may show a newer release later.	−USD 36.33 million Exact value Exact value: -36331302 USD 2006-01-01 – 2006-12-31: -36331302 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2006-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -36331302 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36331302 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-09-000736.txt#35452 The citation records this snapshot. The page link may show a newer release later.	USD 550,929 Exact value Exact value: 550929 USD 2006-01-01 – 2006-12-31: 550929 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2006-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 550929 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 550929 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-09-000736.txt#35708 The citation records this snapshot. The page link may show a newer release later.	−USD 36.88 million Calculation and evidence -36331302 − 550929 USD Exact free cash flow: -36882231 USD 2006-01-01 – 2006-12-31: -36331302 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 550929 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2006-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -36882231 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36331302 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-09-000736.txt#35452 Input fundies:CapitalExpenditure: 550929 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950133-09-000736.txt#35708 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 42.25 million Exact value Exact value: -42249000 USD 2007-01-01 – 2007-12-31: -42249000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2007-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -42249000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42249000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#12915 The citation records this snapshot. The page link may show a newer release later.	−USD 35.26 million Exact value Exact value: -35261000 USD 2007-01-01 – 2007-12-31: -35261000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2007-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -35261000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35261000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599 The citation records this snapshot. The page link may show a newer release later.	USD 1.4 million Exact value Exact value: 1397000 USD 2007-01-01 – 2007-12-31: 1397000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2007-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 1397000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1397000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686 The citation records this snapshot. The page link may show a newer release later.	−USD 36.66 million Calculation and evidence -35261000 − 1397000 USD Exact free cash flow: -36658000 USD 2007-01-01 – 2007-12-31: -35261000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 1397000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2007-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -36658000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35261000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599 Input fundies:CapitalExpenditure: 1397000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 41.58 million Exact value Exact value: -41580000 USD 2008-01-01 – 2008-12-31: -41580000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2008-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -41580000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -41580000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#12915 The citation records this snapshot. The page link may show a newer release later.	−USD 24 million Exact value Exact value: -23996000 USD 2008-01-01 – 2008-12-31: -23996000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2008-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -23996000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23996000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599 The citation records this snapshot. The page link may show a newer release later.	USD 812,000 Exact value Exact value: 812000 USD 2008-01-01 – 2008-12-31: 812000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2008-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 812000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 812000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686 The citation records this snapshot. The page link may show a newer release later.	−USD 24.81 million Calculation and evidence -23996000 − 812000 USD Exact free cash flow: -24808000 USD 2008-01-01 – 2008-12-31: -23996000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 812000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2008-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -24808000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23996000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599 Input fundies:CapitalExpenditure: 812000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 62.33 million Exact value Exact value: -62326000 USD 2009-01-01 – 2009-12-31: -62326000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Net Income: -62326000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62326000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#12915 The citation records this snapshot. The page link may show a newer release later.	−USD 58.16 million Exact value Exact value: -58158000 USD 2009-01-01 – 2009-12-31: -58158000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Operating Cash Flow: -58158000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -58158000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599 The citation records this snapshot. The page link may show a newer release later.	USD 98,000 Exact value Exact value: 98000 USD 2009-01-01 – 2009-12-31: 98000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Capital Expenditure: 98000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 98000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686 The citation records this snapshot. The page link may show a newer release later.	−USD 58.26 million Calculation and evidence -58158000 − 98000 USD Exact free cash flow: -58256000 USD 2009-01-01 – 2009-12-31: -58158000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 98000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MiddleBrook Pharmaceuticals, Inc. · 2009-12-31 MiddleBrook Pharmaceuticals, Inc. (edgar:1161924) Free cash flow: -58256000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1161924?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -58158000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15599 Input fundies:CapitalExpenditure: 98000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1161924/0000950123-10-025277.txt#15686 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001161924, 1161924, edgar:1161924

Also known as ADVANCIS PHARMACEUTICAL CORP

MiddleBrook Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation